Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493

Journal of Interferon and Cytokine Research

Volumn 19, Issue 10, 1999, Pages 1125-1133

  D'souza, M J ^a   Oettinger, C W ^a   Milton, G V ^b   Tracey, K J ^c  

^a MERCER UNIVERSITY   (United States)

^b Dialysis Clinic Inc   (United States)

^c PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEMAPIMOD;

ARTICLE; CYTOKINE PRODUCTION; IMMUNOREGULATION; LETHALITY; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DEPRESSION, CHEMICAL; DISEASE MODELS, ANIMAL; DRUG COMPOUNDING; ENDOTOXEMIA; ESCHERICHIA COLI INFECTIONS; HYDRAZONES; INTERLEUKIN-1; MICROSPHERES; PERITONITIS; RATS; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI;

EID: 0032716821     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313064     Document Type: Article

References (22)

1. REMICK, D.G., KUNKEL, R.G., LARRICK, J.W., and KUNKEL, S.L. (1987). Acute in vivo effects of human recombinant tumor necrosis factor. Lab. Invest. 56, 583-590.
2. TAKAKUWA, T., ENDO, S., NAKAE, H., KIKUCHI, M., BABA, N., INADA, K., and YOSHIDA, M. (1994). Blood cytokine and complement levels in patients with sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84, 291-300.
3. TRACEY, K.J., BEUTLER, B., LOWRY, S.F., MERRY WEATHER, J., WOLPE, S., MILSARK, I.W., HARIRI, R.J., FAHEY, T.J., ZENTELLA, A., ALBERT, I.D., SHIRES, G.T., and CERAMI, A. (1986). Shock and tissue injury induced by recombinant human cachetin. Science 234, 470-474.
4. MOVAT, H.Z. (1987). Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury. J. Lab. Clin. Med. 110, 668-681.
5. EMERSON, T.E., LINDSEY, C.D., JESMOK, G.J., DUERR, M.L., and FOURNEL, M.A. (1992). Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model. Circ. Shock 38, 75-84.
6. HINSHAW, L.B., TEKAMP-OLSON, P., CHANG, A.K.C., LEE, P.A., TAYLOR, F.B., MURRAY, C.K., PEER, G.T., EMERSON, T.E., PASSEY, R.B., and KUO, G.C. (1990). Survival of primates in LD(100) septic shock following therapy with antibody to tumor necrosis factor. Circ. Shock 30, 279-292.
7. ZENI, F., FREEMAN, B., and NATANSON, C. (1997). Antiinflammatory therapies to treat sepsis and septic shock: a reassessment. Critical Care Med. 25, 1095-1100.
8. BIANCHI, M., ULRICH, P., BLOOM, O., MEISTRELL, M., III, ZIMMERMAN, G.A., SCHMIDTMAYEROVA, H., BUKRINSKY, M., DONNELLEY, T., BUCALA, R., SHERRY, B., MANOGUE, K.R., TORTOLANI, A.J., CERAMI, A., and TRACEY, K.J. (1995). An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol. Med. 1, 254-266.
9. BIANCHI, M., ULRICH, P., BLOOM, O., MEISTRELL, M., III, ZIMMERMAN, G.A., SCHMIDTMAYEROVA, H., BUKRINSKY, M., DONNELLEY, T., BUCALA, R., SHERRY, B., MANOGUE, K.R., TORTOLANI, A.J., CERAMI, A., and TRACEY, K.J. (1996). Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J. Exp. Med. 183, 927-936.
10. GERBER, D.A., OETTINGER, C.W., D'SOUZA, M.J., MILTON, G.V., LARSEN, C.P., and PEARSON, T.C. (1995). Prolongation of murine cardiac allograft survival by microspheres containing TNFα and IL-1β neutralizing antibodies. J. Drug Targeting 3, 311-315.
11. OETTINGER, C.W., D'SOUZA, M.J., and MILTON, G.V. (1996). In vitro comparison of cytokine release from antithymocyte serum and OKT3: inhibition with soluble and microencapsulated neutralizing antibodies. Transplantation 62, 1690-1693.
12. OETTINGER, C.W., MILTON, G.V., and D'SOUZA, M. (1999). Targeting macrophages with microspheres containing cytokine neutralizing antibodies prevents lethality in gram-negative peritonitis. J. Cytokine Interferon Res. 19, 33-40.
13. POURFARZIB, R., GAJJAR, D., RIADI, I., and D'SOUZA, M. (1993). Enzyme-linked immunosorbent assay for detection of human tumor necrosis factor alpha. Pharmaceut. Res. 10, S-1-400.
14. POURFARZIB, R., GAJJAR, D., RIADI, I., and D'SOUZA, M. (1993). Enzyme-linked immunosorbent assay for detection of human interleukin 1 beta. Pharmaceut. Res. 10, S-1, 400.
15. BENDER, A., SCHAFER, V., STEFFAN, A.M., ROYER, C., KREUTER, J., RUBSAMEN-WAIGMAN, H., and VON BRIESEN, H. (1994). Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles. Res. Virol. 145, 215-220.
16. SCHAFFER, V., BRIJSEN, H.V., RUBSMEN-WAIGMANN, H., STEFFAN, A.M., ROYERS, C., and KREUTER, J. (1994). Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages. J. Microencapsulation 11, 261-269.
17. COHEN, P.S., HARIKRISHNA, N., DENNIS, J., CARAGINE, T., BIANCHI, M., CERAMI, A., and TRACEY, K.J. (1996). CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc. Natl. Acad. Sci. USA 93, 3967-3971.
18. COHEN, P.S., SCHMIDTMAYEROVA, H., DENNIS, J., DUBROVSKY, L., SHERRY, B., WANG, H., BUKRINSKY, M., and TRACEY, K.J. (1997). The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol. Med. 5, 339-346.
19. BAGBY, G.J., PLESSALA, K.J., WILSON, L.A., THOMPSON, J.J., and NELSON, S. (1991). Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163, 83-88.
20. REMICK, D., MANOHAR, P., BOLGOS, G., RODRIGUEZ, J., MOLDAWER, L., and WOLLENBERG, G. (1995). Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4, 89-95.
21. ESKANDARI, M., BOLGOS, G., MILLER, C., NGUYEN, D., DEFORCE, L., and REMICK, D. (1992). Antitumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148, 2724-2730.
22. ZANETTI, G., HEUMANN, D., GERAIN, J., KOHLER, J., ABBET, P., BARRAS, C., LUCAS, R., GLAUSER, M., and BAUMGARTNER, J. (1992). Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. J. Immunol. 148, 1890-1897.